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Suppl, Table 1: Tracer injections into the LO- and the VLO-cortices that are represented in the 
Allen Database 
Injected 
Area 
Exp. 
number 
Genotype Parvafox Su3 PV
2 
Comments 
PL 26310603
6 
 
Rbp4-
Cre_KL100 
Enriched in layer 
5 
avoided   Innervates a 
large area of 
the lateral 
hypothalamus 
PL 28301934
1 
 
A930038C07Rik
-Tg1-Cre 
Expressed in 
layer 5 
Generall
y strong 
LHA 
  Innervates a 
large area of 
the lateral 
hypothalamus 
ILA 28631349
1 
Rbp4-
Cre_KL100 
Enriched in layer 
5 
+   Strong 
innervation of 
the lateral 
hypothalamus
, minor in the 
region of the 
parvafox, 
More 
perifornical 
large terminal 
field. 
ORBvl 
(76%) 
ORBl 
(8%) 
ORBm 
(2%) PL 
(9%),  
 
11242339
2 
 
C57BL/6J 
WT 
+ + 
dorsomedial 
++ Injection 
slightly medial 
from the 
olfactory 
notch.  
ORBl 
(83%), 
ORBvl 
(16%)  
11230631
6 
 
C57BL/6J 
WT 
++ ++ 
ventromedia
l 
++ Injection that 
corresponds 
best to ours. 
Gemini 
ORBl 
(65%), 
ORBvl 
(33%), 
Fr (2%) 
,  
15674182
6 
Olfactory 
notch 
Rbp4-
Cre_KL100 
enriched in 
cortical layer 5 
+ + 
ventromedia
l 
+ Faint in 
thalamus, 
nothing in 
hindbrain.  
Gemini 
ORBl, 
AiD, AiV 
18070923
0 
C57BL/6J 
WT 
(+) + (+) Strong 
projection in 
the insular 
cortex 
Gemini 
ORBvl, 
ORBl 
MOS 
ILA 
  
18361884
5 
Olfactory 
notch 
Htr2a-
Cre_KM207 
Enriched in layer 
5 and 6b 
+ + 
whole Su3 
+ Gemini 
ORBl 
(65%), 
ORBvl 
(35%)  
16816497
2 
Olfactory 
notch 
A930038C07Rik
-Tg1-Cre 
restricted to 
layer 5 
+ + 
whole Su3 
++ Thalamus 
only in Sub, 
rest faint 
ORBl, 
FRP, 
MOs, 
ORBvl, 
Ald, 
AOB 
28832421
1 
Grp-Cre_KH288 
GPR-Cre 
Enriched in layer 
2-3 
- - - Reaches only 
until the 
striatum. 
Contingent of 
axons until 
brainstem 
ORBl, 
FRP, 
MOs, 
ORBvl, 
Ald, 
AOB 
26571368
3 
Gpr26-
Cre_KO250 
Enriched in 5 
and 6b 
(+) (+) (+) Faint  
ORBl, 
Mop, 
ORBvl, 
Ald 
12635345
1 
Syt6-Cre_KI148 
Enriched in layer 
6a 
(+) (+) (+) Reaches 
thalamus but 
no terminals in 
the striatum. 
Few endings 
parvafox, Su3 
and PV2 
ORBl, 
MOs, 
Ald 
15988762
7 
Nr5a1-Cre 
Restricted to 
layer 4 
- - - Reaches only 
striatum 
ORBVl 18347117
4 
Enriched in 
layers 2,3,4 
- - - Reaches 
striatum, very 
few terminals 
in thalamus 
ORBl, 
Mop, 
MOs, 
ORBvl 
27817445
1 
Chrna2-
Cre_OE25 
Enriched in layer 
5 
(+) (+) (+) Precise, small 
injection, 
slender 
projection 
ORBl, 
Mop, 
MOs, 
ILA, 
ORBvl, 
Ald, Alv 
30776662
7 
Etv1-CreERT2 
Enriched in layer 
5 
(+) - (+) No endings in 
striatum, only 
in thalamus, 
Gemini 
ORBM, 
MOs, 
ACAd, 
PL, ILA, 
ORBvl 
49655423
7 
Rbp4-
Cre_KL100 
Enriched in layer 
5 
(+) (+) (+) Terminals in 
the whole 
lateral 
hypothalamus
, but not 
concentrated 
in the 
parvafox-
nucleus. 
ORBm, 
ILA, 
ORBvl 
26582021
6 
Syt6-Cre_KI148 
Enriched in 6a 
- - - Reaches until 
thalamus. No 
terminals in 
striatum 
ORBm, 
ACAd, 
27795649
6 
Htr2a-
Cre_KM207 
(+) - - String 
projection 
PL, ILA, 
ORBvl 
Expression in 
layers 5 and 6b 
ORBm, 
FRP, 
MOs,PL
, ILA, 
ORBvl 
29789284
3 
Chrna2-
Cre_OE25 
Enriched in layer 
5 
- - - Small 
injection, 
string-like 
descending 
projection 
ORBVl 28776928
6 
Rbp4-
Cre_KL100 
Enriched in layer 
5 
 
+ + 
dorsomedial 
++ Nice 
specimen 
Gemini 
ORBvl, 
MOs, 
ACAd, 
PL, ILA, 
ORBl, 
ORBm 
16790258
6 
Rbp4-
Cre_KL100 
Enriched in layer 
5 
+ + 
dorsomedial 
+ Very large 
injection, 
clearly 
transgressing 
the 
boundaries of 
VLO, Gemini 
ORBvl, 
ILA, 
ORBl 
15843511
6 
C57BL/6J 
WT 
- - (+) Slender, in 
thalamus only 
Sub. 
Extensive 
cortical 
projections  
ORBVl, 
ORBm 
26656402
7 
Only layer 2-3 - - - Goes until 
striatum, no 
further 
 
Suppl. Table 1: ABA-data appertaining to 24 experiments in which tracers were injected into 
the LO-or the VLO- portion of the orbitofrontal cortex. With the exception of six wild–type 
(C57/BI6) mice, all others were genetically modified to express Cre-recombinase in specific 
sub-populations of neurons or cortical layers. The nomenclature corresponds to that utilized in 
the ABA. Translation to the (Franklin and Paxinos, 2008) abbreviations are as follows : ORBl 
= LO-cortex; ORBvl = VLO-cortex; ORVmN= MO; MOs = M2; Mop = M1; FRP = FrA cortex; 
ILA = IL-cortex; ACAd: Cg1; PL= PrL. 
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Supplementary material 
 
Supplementary Results 
In the rodent OFC, the position of the medial boundary between the LO- and the VLO-cortices is not 
generally agreed upon by all authors. In some publications, the VLO-cortex in rats straddles laterally 
to the olfactory notch (Groenewegen, 1988; Yoshida et al., 1992), whereas in others, it borders the 
olfactory notch medially (Krettek and Price, 1977; Reep et al., 1996). In Paxinos’ atlases of the rat 
(Wistar) and mouse (C57Bl/J6) brains, (Paxinos and Franklin, 2013; Paxinos and Watson, 2009), 
the VLO-cortex is not mapped, whereas in Swanson’s atlas of the Sprague-Dawley rat brain  
(Swanson, 2004) it is; and likewise in the  Allen Brain Institute mouse brain atlas (C57Black/6) (Dong, 
2008). The arguments that come into play for setting the position of the boundary between the LO-  
and the VLO-cortices  medial to the olfactory notch are namely that the latter region has privileged 
connections with the submedius thalamic nucleus and has reciprocal connections with the visual 
association areas C2M and Oc2L (Ray and Price, 1992; Reep et al., 1996). The lateral boundaries 
of the LO-cortex, on the other hand, are generally agreed upon; they coincide with the lateral border 
of the upper lip of the rhinal fissure. In our schematic drawings (e.g. Fig. 1 and 2), the subdivision of 
the orbitofrontal cortex in LO and VLO cortex has been adopted. 
 
The Su3- and the PV2 nuclei 
The Su3 nucleus (Carrive and Paxinos, 1994), which has a length of 40 µm in mice, is located ventral 
to the aqueduct, at the edge of the PAG between Bregma levels -3.80 and -4.20 (Franklin and 
Paxinos, 2008). In rats, it is located between Bregma  levels -6 and -7 (Paxinos and Watson, 2009). 
The Su3 nucleus, which receive a strong parv-positive terminal field from the parvafox nucleus 
(Bilella et al., 2016c; Celio et al., 2013), constitutes one of the triple-layered structures that mantles 
the oculomotor nucleus, being sandwiched between an NADH-immunoreactive cap (Su3C) and a 
parvicellular band of cells (3PC), which projects to the abducens nucleus (Van Bockstaele and 
Aston-Jones, 1992). The dorsomedial half of the Su3 nucleus, which the findings of our study 
revealed to be targeted by the VLO-cortex, projects to the rostral and the caudal ventrolateral 
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medulla, namely, to the cardiovascular and the respiratory sites in the medulla oblongata (Chen and 
Aston-Jones, 1996; Ennis et al., 1997; Van Bockstaele et al., 1991). Although the ventrolateral 
portion of the Su3 nucleus is shown in our report to receive terminals from the LO-cortex (e.g. Fig 
3M, 4A-C), the targets of its projections have not been identified. 
 
The PV2 nucleus has been described only recently (Celio et al., 2013) as an elongated column of 
parv-expressing neurons, visible in the cross section of Fig. 4I. In mice, it has a length of 
approximately 40 m and is located ventral to the aqueduct, at the edge of the PAG extending 
between Bregma levels -4.60 and -5.05 (Franklin and Paxinos, 2008). In rats, it is located between 
Bregma levels -7.50 and -8.50 (Paxinos et al., 2009). Rostrally, it occupies the most ventral portion 
of the lateral dorsal raphe nucleus (DRL) – although it is not itself catecholaminergic (Fig. 4H) – and 
the most lateral region of the posterodorsal raphe nucleus (PDR), arching over the boundary of the 
isthmic reticular formation (isRT). The PV2 nucleus receives afferences from the two sub-populations 
of nerve cells of which the hypothalamic parvafox nucleus is composed, namely, the Pvalb- (Celio 
et al., 2013) and the Foxb1-expressing neurons (Bilella et al., 2016a). No information appertaining 
to its other connections and functions has yet been forthcoming. 
 
Supplementary results 
Connections that confirms, specify or describes differences between known projections of 
the LO-VLO cortex. 
Cerebral cortex 
The projections from the LO/VLO cortex targeted the contralateral cortical regions homotypical to 
the injection site. The LO-cortex innervated the granular and the agranular portions of the insular 
area and the Par2 (S2-cortex), as has been reported also by others (Reep et al., 1996). It projected 
descending axons to layer III of the piriform cortex (Illig, 2005), as well as to the  temporal sensory 
and the secondary motor cortices (Bedwell et al., 2015; Bedwell et al., 2014). Projections from the 
VLO-cortex extended to the visual and the temporal cortices (Fig. 7B and C). 
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Basal forebrain  
Some of the labelled axons coursed ventrally to the piriform cortex, whilst others left the striatum in 
the directions of the HDB, the SI and the olfactory tubercle (Fig. 7A, C). Endings were observed in 
the HDB in the region of the basal nucleus and in the magnocellular preoptic nucleus. These findings 
confirm those of other tracer experiments involving the Phaseolus vulgaris leucoagglutinin 
(Gaykema et al., 1991): injection RG137, figure 8; (Berendse et al., 1992; Zaborszky et al., 1997), 
which was injected into the LO- and the VLO-cortices (their cases 001, 026 and 085 in Fig. 5).   
 
The caudatoputamen and olfactory sites 
Axons leaving the OFC ascended to the external capsule and there formed tiny fascicles that entered 
the rostral part of the caudatoputamen, travelling in a dorsolateral-to-ventromedial direction 
throughout its extent (Fig. 7A). Axons deriving from neurons in the VLO-cortex were located more 
medially than were those arising from neurons in the LO-cortex, which confirms the findings of others 
(Berendse et al., 1992; McGeorge and Faull, 1989). When the injection hit the LO-cortex, an 
extensive terminal field arising from these axons was apparent in the ventrolateral quadrant; when it 
hit the VLO-cortex the terminal field was located in the laterodorsal quadrant, as has been previously 
described (Berendse et al., 1992; McGeorge and Faull, 1989; Zaborszky et al., 1997). The terminals 
infiltrated the matrix of the caudatoputamen but not the patches. A less dense mirror-projection, 
involving axons that were passing through the lower third of the Genu corporis callosi was observed 
in the contralateral caudatoputamen. Terminals were also detected in the shell of the accumbens 
(Acbsh); less so in the core region of the same nucleus (Acbc) and in the ventral Globus pallidus. 
The axons then converged in the ventromedial sector of the internal capsule and continued their 
course in the crus cerebri.  
Diencephalon 
Thalamus 
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From the axons that are located in the ventromedial sector of the internal capsule in the 
diencephalon, collaterals ascended to the inferior thalamic peduncle. They delaminated in the 
dorsomedial direction, forming terminal fields in the ventromedial tip of the reticular nucleus, the 
anterior thalamic nuclei (VA, VM, VL), the dorsolateral portion of the RE, the ventral half of the 
submedius nucleus (for the LO-cortex), and after piercing the internal medullary lamina, the MDC, 
the caudatus/pallidus-strip, the intralaminar nuclei [medial central (CM), paracentral (PC), lateral 
central (CL)], the posterior- and for the VLO-cortex, the parafascicular nuclei (Fig. 7C) (Jones and 
Leavitt, 1974). The nucleus submedius was a preferred target of the orbitofrontal projections from 
the VLO-, as has been already recognized by other authors (Coffield et al., 1992; Craig et al., 1982; 
Meyer, 1949; Yoshida et al., 1992). Only the ventral half received LO-derived terminals. 
Although labelling in the mediodorsal nucleus was most intense in the central subnucleus, terminals 
were nevertheless always observed in the lateral and the medial segments. The thalamic field of 
terminals in the magnocellular portion of the MD corresponds to that of the LO- cortex in the thalamus 
(Uylings and van Eden, 1990). The relationship between the LO- cortex and the thalamus is 
reciprocal for the central segment of the mediodorsal nucleus, the ventral portion of the submedial 
nucleus and the ventromedial nucleus (Craig et al., 1982; Reep et al., 1996). Labelling of the thalamic 
nuclei was always bilateral and symmetrical, but was more intense on the ipsilateral side. A portion 
of the fibres gained access to the contralateral side via intrathalamic decussation. 
 
Amygdala 
At the same rostrocaudal level, a contingent of the labelled OFC- derived collaterals swerved 
ventrolaterally from the main corticofugal pathway to specifically innervate the lateral and the 
basolateral nuclei in the amygdala (Bregma level: 0.94; Fig. 7C), particularly when the injections 
encroached on the LO- or the insular cortex (AiD and AiV). The bodies of the nerve cells in the 
basolateral amygdala were also labelled (not shown), which is a rare but not an unknown occurrence 
(Chamberlin et al., 1998) of a retrograde-transport of the AAV-virus. This phenomenon can also be 
observed in the ABA-injections (e.g. image 64 of the injection Nr. 112306316). 
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Glutamate and GABA in the OFC axons targeting the parvafox 
The identity of the neurotransmitter that is expressed by the LO/VLO-cortex-derived terminals in the 
parvafox nucleus and by those in the PAG was revealed immunohistochemically after exposing the 
specimens to antibodies against various vesicular glutamate transporters (Vglut1, Vglut2) and 
enzyme (GAD). Three-dimensional reconstructions of images that were recorded in the confocal 
scanning microscope revealed the primary neurotransmitter to be glutamate, which was retrieved in 
the synaptic vesicles by Vglut2 (suppl. Fig. 2 A, B). These findings correspond to those that have 
been recorded for terminals from the OFC to the basal forebrain (Zaborszky et al., 1997). But in 
addition, some of the terminals were revealed to use Vglut1 as a vesicular transporter (suppl. Fig. 2 
C,D) or to express GAD (suppl. Fig. 2 E, F). The GAD-immunoreactive terminals may derive from 
the parvalbumin-expressing neurons in the LO-cortex, which contribute to the axonal projection to 
the parvafox nucleus. Recently, also glycine-expressing terminals probably deriving from the 
brainstem have been observed to abut on Glyt2–receptor–immunoreactive neurons in the parvafox 
nucleus (Szabolcsi et al., 2017).  
 
Supplementary Figures 
 
Supplementary Fig. 1: 
LO/VLO terminals express mainly excitatory synapses 
 
Ultrastructural study of contacts between terminals descending from the OFC and neurons in the 
region of the parvafox. The most common GFP-positive terminals were of the asymmetric type 
(marked with an arrow in panel A) and contained round synaptic vesicles (rsv). These synapses are 
known to be excitatory. The GFP-positive terminals (*) themselves, were targeted by both excitatory 
(arrow in B) or by symmetric, inhibitory synapses, characterized by presynaptic flat vesicles (fv; arrow 
in C; the inset shows a magnified view). These images were obtained on the brain of mouse 127-
13. Scale bar: 1 m. 
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Supplementary Fig. 2:  
Neurotransmitters utilized by the LO/VLO projection 
 
Co-existence of glutamatergic (VGlut1 or VGlut2) immunoreactivity or GABAergic (GAD 
immunoreactivity) markers in the terminal endings of the OFC-projection (labelled with AAV-tomato) 
in the parvafox nucleus. 
Three horizontal sections through the level of the parvafox nucleus in the ventrolateral hypothalamus 
were immunostained with antibodies against the vesicular glutamate transporters Vglut 2 (panels A-
C), VGkut 1 (panels C, D), respectively the GAD-enzyme (panel E, F). B, D and F show the framed 
area in A, C, D respectively under higher magnification. The yellow dots in the higher magnificataion 
images of panels B and D indicate the expression of Vglut1 or Vglut 2 in “boutons terminaux” or 
axons from the OFC. The white dots in F indicate the expression of GAD in Parv-positive terminals 
at the surface of Parv-neurons of the parvafox. These images were obtained with the brain of mouse 
394-13. Scale bars: A, C, E: 250 m; B, D, F: 50 m. 
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